TriSalus Life Sciences® Inc. ("TriSalus" or the "Company") (Nasdaq: TLSI), an oncology company dedicated to enhancing outcomes for patients with liver and pancreatic cancer through its advanced ...
Hims stock popped Monday after the Food and Drug Administration reportedly said it would reconsider its decision to bar compounders from selling knockoff versions of Eli Lilly's obesity and diabetes ...